My complete blood count shows a relative neutrophilia (74% neutrophils) and borderline low MCHC (31.9 g/dL) with otherwise normal values; what is the clinical significance and should I pursue further evaluation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Significance of Mild Neutrophilia and Borderline Low MCHC

Your complete blood count shows a mild relative neutrophilia (74.2%) with an absolute neutrophil count of 7.4 × 10³/µL and a borderline low MCHC of 31.9 g/dL; these findings are clinically insignificant in an asymptomatic individual and do not require further evaluation at this time.

Assessment of Neutrophilia

Absolute vs. Relative Neutrophilia

  • Your absolute neutrophil count (ANC) of 7.4 × 10³/µL is within the normal reference range (1.5–8.0 × 10³/µL), indicating that you do not have true neutrophilia despite the elevated percentage. 1

  • The neutrophil percentage of 74.2% represents a mild relative increase above the reference range (34.0–73.0%), but this is not clinically significant when the absolute count is normal. 2

  • The most diagnostically powerful markers for bacterial infection are absolute band count ≥1,500 cells/mm³ (likelihood ratio 14.5), neutrophil percentage >90% (likelihood ratio 7.5), and left shift ≥16% bands (likelihood ratio 4.7). Your neutrophil percentage of 74.2% does not reach the >90% threshold that carries high likelihood of serious bacterial infection. 2

Clinical Context

  • In the absence of fever, symptoms, or other clinical manifestations of infection, a neutrophil percentage of 74.2% with normal total WBC (9.9 × 10³/µL) does not warrant additional diagnostic testing. 2

  • Physiologic stressors such as recent exercise, emotional stress, or minor illness can produce transient shifts in neutrophil percentages without indicating pathology. 2

Assessment of Borderline Low MCHC

Technical Considerations

  • Your MCHC of 31.9 g/dL is only 0.1 g/dL below the lower reference limit (32.0–35.5 g/dL), which falls within normal laboratory variation and is not clinically significant. 3, 4

  • MCHC can be falsely affected by technical factors including cold agglutination, lipemia, or sample storage conditions; a value this close to the reference range does not indicate true pathology. 4

  • Your hemoglobin (14.3 g/dL) and hematocrit (44.8%) are both normal, and your red blood cell indices (MCV 85.2 fL, MCH 27.2 pg) are within normal limits, making clinically significant anemia or hemoglobinopathy extremely unlikely. 3, 5

Iron Status Assessment

  • Your RDW of 12.7% is normal (11.0–15.0%), which argues against iron deficiency or other causes of anisocytosis that would be expected if the low MCHC were pathologic. 6, 7

  • True iron deficiency typically presents with low MCV (<80 fL), elevated RDW (>15%), and MCHC significantly below 31 g/dL; none of these features are present in your case. 6

Recommended Management

No Further Testing Required

  • For asymptomatic patients with mild neutrophilia (ANC within normal range) and borderline laboratory values, repeat testing is not indicated unless symptoms develop. 1, 2

  • Do not order additional tests such as iron studies, peripheral blood smear, or inflammatory markers in the absence of clinical symptoms or other CBC abnormalities. 2, 8

Monitoring Approach

  • If you remain asymptomatic, no follow-up CBC is necessary. 1

  • Seek medical evaluation if you develop fever (≥38.3°C or ≥38.0°C sustained ≥1 hour), unexplained fatigue, bleeding, bruising, or other systemic symptoms. 1

Critical Pitfalls to Avoid

  • Do not pursue extensive workup for relative neutrophilia when the absolute neutrophil count is normal; this leads to unnecessary testing and patient anxiety. 2

  • Do not treat borderline MCHC values as clinically significant anemia when hemoglobin, hematocrit, and other red cell indices are normal. 3, 4

  • Do not order iron supplementation based solely on a borderline low MCHC without evidence of iron deficiency (low ferritin, low transferrin saturation, or microcytic anemia). 6

References

Guideline

Neutropenia Management and Classification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Neutrophilia Causes and Diagnostic Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

The complete blood count: physiologic basis and clinical usage.

The Journal of perinatal & neonatal nursing, 1997

Research

Two Cases of False Elevation of MCHC.

Clinical laboratory, 2024

Research

Understanding the complete blood count with differential.

Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses, 2003

Guideline

Assessment Protocol for Incidental Erythrocytosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the normal lab value ranges in a Complete Blood Count (CBC) with differential?
Is a complete blood count (CBC) with differential a reasonable initial test in a patient presenting with fever?
Is this complete blood count (CBC) with WBC 10.1 ×10³/µL, neutrophils 7.2 ×10³/µL, lymphocytes 2.2 ×10³/µL, monocytes 0.56 ×10³/µL, eosinophils 0.051 ×10³/µL, basophils 0.04 ×10³/µL, RBC 4.69 ×10⁶/µL, hemoglobin 13.9 g/dL, hematocrit 43.5 %, MCV 92.8 fL, MCH 29.6 pg, MCHC 32.0 g/dL, RDW 13.9 %, platelets 320 ×10³/µL, MPV 11.3 fL normal or concerning?
What blood work is recommended for a general health assessment?
What is the management plan for abnormal Complete Blood Count (CBC) results?
In a 30-year-old woman with surgically induced menopause, when should dual-energy X-ray absorptiometry (DEXA) scans be started?
What is the recommended outpatient antibiotic regimen for preseptal cellulitis?
What are the recommended dosing regimens, contraindications, and common adverse effects of tadalafil (phosphodiesterase‑5 inhibitor) for erectile dysfunction in adult men?
What is the safest evidence‑based first‑line pharmacologic regimen for a 17‑year‑old adolescent with major depressive disorder, generalized anxiety disorder, and post‑traumatic stress disorder?
In a pregnant patient with persistent constipation despite using Restoralax (polyethylene glycol 3350), what are the next safe treatment options?
What is the highest target dose of quetiapine (Seroquel) for treating schizophrenia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.